Kings Path Partners »

Biosante Pharmaceuticals shares owned by Kings Path Partners

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.0M 16k 63.68

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Schwab Strategic Tr Us Tips Etf (SCHP)

View all positions for Kings Path Partners

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Dimensional Fund Advisors
Rubric Capital Management
Global Alpha Capital Management
William Blair Investment Management
Deep Track Capital
Tang Capital Management
Geode Capital Management
Ranger Investment Management
Citadel Advisors
Macquarie Group
Nuveen Asset Management
Invesco

View all funds holding Biosante Pharmaceuticals